Replies to post #163366 on Biotech Values

[biomaven0]

No, can't have as much confidence for Crohn's - in RA we already have very good evidence of efficacy.

At this early stage I merely have hopes for efficacy in autoimmune diseases - way too early to have expectations yet.

Peter